Table 3.
Performance Characteristics (Sensitivity, Specificity, and Imageability/Gradability) for Subject Eyes with Dilated Ophthalmoscopy Examinations at Nonretina Sites (N = 778), Retina Sites (N = 221), and Total (N = 999)
| Cohort (No. of Eyes with CRS) | Screening Methodology | Sensitivity (95% CI) | Specificity (95% CI) | Imageability/Gradability (95% CI) |
|---|---|---|---|---|
| Subjects with dilated ophthalmoscopy (n = 999 eyes) | Dilated ophthalmoscopy | 27.7% [20.1%–35.2%] | 99.6% [99.1%– 100.0%] | 99.9% [99.7%–100.0%] |
| EyeArt system (with dilation-if-needed) (147 eyes dilated) |
96.4% [93.1%–99.8%] | 88.4% [85.8%–91.1%] | 97.4% [96.0%–98.8%] | |
| Subjects enrolled at nonretina specialty centers (n = 778 eyes) | Dilated ophthalmoscopy | 20.6% [13.1%–28.0%] | 99.8% [99.5%–100.0%] | 99.9% [99.6%–100.0%] |
| EyeArt system (with dilation-if-needed) (109 eyes dilated) |
96.5% [92.9%–100.0%] | 86.3% [83.0%–89.7%] | 97.6% [96.0%–99.1%] | |
| Subjects enrolled at retina specialty centers (n = 221 eyes) | Dilated ophthalmoscopy | 59.5% [40.2%–78.7%] | 98.9% [97.1%– 100.0%] | 100.0% [100.0%–100.0%] |
| EyeArt system (with dilation-if-needed) (38 eyes dilated) |
97.3% [90.3%–100.0%] | 88.0% [82.5%–93.5%] | 96.8% [93.6%–100.0%] |
CI = confidence interval; CRS = clinical reference standard (as per reading center).